ASCO Annual Meeting 2023: Less-Extensive Hysterectomy Is Effective in Early Cervical Cancer and Adding Ribociclib to Hormone Therapy Lowers Risk of Breast Cancer Recurrence
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. This research explores using less extensive surgery for cervical cancer and using targeted therapy to reduce the risk of breast cancer recurrence.